RecruitingNot ApplicableNCT06647589

Acceptance and Commitment Therapy for Religious OCD

Efficacy of Acceptance and Commitment Therapy on Religiously Oriented Obsessive-Compulsive Disorder


Sponsor

University of Alabama at Birmingham

Enrollment

10 participants

Start Date

Jul 30, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of the study is to examine the effects and feasibility of a specific form of psychotherapy, acceptance and commitment therapy (ACT), on religiously oriented obsessive and compulsive disorder (OCD).


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing Acceptance and Commitment Therapy (ACT) — a type of talk therapy focused on accepting difficult thoughts and committing to meaningful values — specifically adapted for people with religious OCD (also known as scrupulosity), a form of OCD where intrusive thoughts or compulsions center around religious or moral concerns. **You may be eligible if...** - You are 18 years or older - You meet the scoring threshold for scrupulosity (religious OCD) on a standardized screening questionnaire **You may NOT be eligible if...** - You have experienced psychotic symptoms (e.g., hallucinations, delusions) in the past 6 months - You have had active suicidal or homicidal thoughts, plans, or a recent attempt in the past 6 months - You have engaged in non-suicidal self-injury in the past 6 months - You have used narcotics in the past 3 months - You have had purging or restricting behaviors related to an eating disorder in the past 3 months Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALAcceptance and Commitment Therapy

participants will then receive ACT-based individual therapy weekly for twelve weeks.


Locations(1)

University of Alabama at Birmingham

Birmingham, Alabama, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06647589


Related Trials